| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146661da348ab185cfd900580e2040f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b96216b36f3c4e0f16a9cf29f233c51 |
| publicationDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020181034-A1 |
| titleOfInvention |
Jak1 pathway inhibitors for the treatment of chronic lung allograft dysfunction |
| abstract |
This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11713315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702415-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947229-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10968222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836763-B2 |
| priorityDate |
2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |